Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 25, 2012
Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesisNicolas Sévère, François-Xavier Dieudonné, Caroline Marty, et al.
Journal of Cellular Physiology|March 26, 2014
N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during agingEric Haÿ, François-Xavier Dieudonné, Zuzana Saidak, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Gene|April 2, 2013
ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivoNicolas Jullien, François-Xavier Dieudonné, Nadia Habel, et al.
The Journal of Experimental Medicine|July 22, 2009
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophiliaIsabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, et al.
Blood|July 11, 2009
Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokinesAbire Jedidi, Caroline Marty, Charleen Oligo, et al.
Pageof 16